Drug intelligence / Profile preview

Supraz

Development stage: Phase 3
Modality: Small Molecules
Administration: Topical

Overview

Supraz is a specialized repairing gel formulated for the management of chronic and recalcitrant wounds. It is specifically designed to eliminate wound odor and promote healing in difficult-to-treat injuries, such as diabetic ulcers or pressure sores. The gel is often utilized in combination with platelet-rich plasma-fibrin glue (PRP-FG) to enhance regenerative processes. Its formulation typically includes components intended to maintain a moist wound environment and reduce malodor associated with bacterial colonization in necrotic tissues.

Brand names: Supraz
Other names: Supraz gelSupraz repairing gel

Beyond the preview

Go deeper on Supraz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supraz.

Explore the full profile